PUBLISHER: The Business Research Company | PRODUCT CODE: 1662508
PUBLISHER: The Business Research Company | PRODUCT CODE: 1662508
Animal health encompasses the study and management of animal diseases, considering the interrelation between animal welfare, environmental protection, human health, and food safety. It involves practices and products aimed at ensuring the healthy development and well-being of animals.
The primary products within the animal health market include vaccines, pharmaceuticals, medicinal feed additives, diagnostics, equipment and disposables, and other related items. Commercial animals or livestock refer to living animals grown or raised for commercial purposes. Animal health products are employed to enhance the productivity of commercial animals, generate income, and maintain overall disease-free conditions. These products are administered through various routes, including oral, parenteral, and topical methods, and are utilized by both commercial and companion animal types. End users of animal health products include veterinary hospitals and clinics, animal care and rehabilitation centers, as well as diagnostic centers.
The animal health market research report is one of a series of new reports from The Business Research Company that provides animal health market statistics, including animal health industry global market size, regional shares, competitors with an animal health market share, detailed animal health market segments, market trends, and opportunities, and any further data you may need to thrive in the animal health industry. This animal health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The animal health market size has grown strongly in recent years. It will grow from $55.26 billion in 2024 to $59.91 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to globalization of food supply chains, intensification of livestock farming, increase in zoonotic diseases, regulatory compliance and standards, preventive healthcare emphasis.
The animal health market size is expected to see strong growth in the next few years. It will grow to $82.04 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to focus on aquaculture health, one health approach, global efforts in disease surveillance, expansion of pet insurance, crisis preparedness in animal agriculture, globalization of animal health products. Major trends in the forecast period include technological integration in diagnostics, biotechnology and genomics, adoption of telehealth services, digitalization of supply chain and distribution, collaborative research initiatives.
The rising incidence of zoonotic diseases is expected to drive the growth of the animal health market in the coming years. Zoonotic diseases are infectious diseases that can be transmitted between various animal species and humans, or vice versa. Effective monitoring and safeguarding of animal health through various methods are crucial for controlling zoonosis and protecting public health. For example, in June 2023, a report from the National Library of Medicine, a US government-operated institution, highlighted that zoonotic diseases are responsible for approximately 2.5 billion human cases worldwide and around 2.7 million deaths each year. Consequently, the increasing prevalence of zoonotic diseases is set to boost the animal health market.
The increasing traction for pet insurance is projected to propel the expansion of the animal health market. Pet insurance serves as a financial safeguard covering a portion of veterinary expenses related to pet care, aiding pet owners in managing their healthcare costs. It promotes animal health by offering financial support, encouraging preventive care measures, and fostering responsible pet ownership. For instance, data from the North American Pet Health Insurance Association indicates that the number of insured pets in North America surged to 5.36 million in 2022, marking a notable 21.7% increase from 2021's 4.4 million. Hence, the rising demand for pet insurance emerges as a significant driver propelling the growth of the animal health market.
Technological advancements represent a pivotal trend gaining momentum within the animal health market. Key industry players are intensifying their focus on introducing innovative and sophisticated technologies to fortify their market positions. For instance, in April 2022, Elanco Animal Health Incorporated and Ginkgo Bioworks collaborated to introduce a groundbreaking product named Animo GPS under the Merck Animal Health portfolio. Animo GPS, designed for dogs, integrates GPS tracking with activity and behavior monitoring. Equipped with smart technology, this device tracks individual canine activity levels and behaviors, offering real-time updates through an intuitive mobile application. Notably, the device records behaviors such as barking, scratching, shaking, and sleep duration, utilizing an adaptive algorithm to analyze deviations and promptly alert pet owners through the app. This technological innovation embodies a significant stride toward enhancing pet care and underscores the market's orientation toward cutting-edge solutions.
Leading companies within the animal health market are forging ahead with innovative products such as the Lactate Scout Vet, aiming to secure a competitive edge. This particular product serves as a point-of-care lactate analyzer, significantly enhancing animal health by delivering rapid and precise lactate measurements. For example, in December 2022, EKF Diagnostics, a UK-based healthcare company, introduced the Lactate Scout Vet. Tailored specifically for veterinarians and animal welfare professionals, this device furnishes accurate lactate measurements within a mere 10 seconds. Notably, it features an e-paper display designed to augment result readability. The Lactate Scout Vet caters to various animals such as dogs, horses, pigs, and cattle, aiding in the prognosis and diagnosis of a wide array of animal health conditions, including shock, severe sepsis, low cardiac output, liver failure, poisoning, and drug therapy.
In July 2022, Dechra Pharmaceuticals plc, a UK-based enterprise specializing in the development and marketing of veterinary products, completed the acquisition of Piedmont Animal Health for $210 million. Through this strategic acquisition, Dechra Pharmaceuticals plc will pivot its focus towards the expansion of its human health business. Piedmont Animal Health, a US-based specialty pharmaceutical company, is renowned for its contributions in therapeutics for both human and animal health. This acquisition marks a strategic shift for Dechra Pharmaceuticals, signaling a concentrated effort to steer its growth trajectory towards the human health sector, further consolidating its position and diversification within the pharmaceutical industry.
Major companies operating in the animal health market include Elanco Animal Health Incorporated, Merck Animal Health, Boehringer Ingelheim International GmbH, Heska Corporation, Vetoquinol SA, Virbac, Bayer AG, Novartis AG, Biogenesis Bago, Intervet International BV, IDEXX Laboratories Inc., Hester Biosciences Ltd., Intas Pharmaceutucals Ltd., Dechra Pharmaceuticals, Kindred Biosciences, Phibro Animal Health Corporation, Neogen Corporation, Norbrook Laboratories, Huvepharma EOOD, Abaxis Inc., ECO Animal Health Group, Hipra, Zoetis Inc., Kemin Industries, DeLaval, Troy Laboratories, Parnell Pharmaceuticals, Ceva Sante Animale, Bimeda Inc., Animalcare Group, PetIQ, AdvaVet Inc.
North America was the largest region in the animal health market in 2024. The regions covered in the animal health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the animal health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The animal health market consists of sales of biologics and flea and tick medications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Animal Health Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on animal health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for animal health ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The animal health market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.